To further investigate the relationship between changes in albumin (Alb) levels and the efficacy of targeted therapy in patients with AIDS-related non-Hodgkin lymphoma (AR-NHL), both before and after treatment, we innovatively introduced the Alb Change Rate as a novel indicator. Here, ALB is linked to non-Hodgkin lymphoma.